Compare Enveric Biosciences Inc (ENVB) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while State Street SPDR S&P Biotech ETF trades at $157.99. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | XBI | |
|---|---|---|
Market Cap | $6.20M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $17.40 | $164.28 |
52-Week Low | $1.27 | $86.92 |
Enterprise Value | $1.30M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
